Comorbidities associated with regional variations in COVID-19 mortality revealed by population-level analysis

Hongxing Yang, Fei Zhong
doi: https://doi.org/10.1101/2020.07.27.20158105

Article Information

doi 
https://doi.org/10.1101/2020.07.27.20158105
History 
  • July 29, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Hongxing Yang1 and
  2. Fei Zhong2,*
  1. 1Merck Holding (China), Shanghai, China, a business of Merck KGaA, Darmstadt, Germany
  2. 2MilliporeSigma, St. Louis, Missouri, a business of Merck KGaA, Darmstadt, Germany
  1. ↵*Corresponding author:
    Fei Zhong, Head of R&D, Lab management, and Bioinformatics, MilliporeSigma, 3050 Spruce Street, MO-63103-2350 St. Louis, MO 100092 USA, E-mail: fei.zhong{at}milliporesigma.com
Back to top
Posted July 29, 2020.
Download PDF
Data/Code
Email
Comorbidities associated with regional variations in COVID-19 mortality revealed by population-level analysis
Hongxing Yang, Fei Zhong
medRxiv 2020.07.27.20158105; doi: https://doi.org/10.1101/2020.07.27.20158105
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area